PD Dr. Markus Hecht



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Pilot Project for App-based Patient Connection in outpatient Tumor Therapy (2022) Hecht M, Goldbrunner L, Kaul F, Winkler S, Ploner N, Lettmaier S, Haderlein M, et al. Conference contribution In the Case of Radiochemotherapy of advanced Rectal Cancer, there is only slight gender-related Differences, none in terms of Radiation Sensitivity! (2022) Schuster B, Hecht M, Schmidt M, Haderlein M, Jost T, Geinitz H, Fietkau R, Distel L Conference contribution Auswirkungen der Kombination des Ligase IV Inhibitors SCR7 mit ionisierender Strahlung auf HNO-Tumorzelllinien und Normalgewebszellen (2022) Hildebrand L, Jost T, Hecht M, Fietkau R, Distel L Conference contribution, Abstract of a poster Influence of alectinib and crizotinib on ionizing radiation - in vitro analysis of ALK/ROS1-wildtype lung tissue cells (2022) Jost T, Schultz AK, Frey B, Vu J, Fietkau R, Distel L, Hecht M Journal article Kinase inhibitors increase individual radiation sensitivity in normal cells of cancer patients (2022) Jost T, Schuster B, Heinzerling L, Weissmann T, Fietkau R, Distel L, Hecht M Journal article Advance directives in patients with head and neck cancer - status quo and factors influencing their creation (2022) Allner M, Gostian M, Rupp R, Allner C, Mantsopoulos K, Ostgathe C, Iro H, et al. Journal article Machine learning based on blood biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy (2022) Zhou JG, Yang J, Wang H, Wong AHH, Tan F, Chen X, He S, et al. Conference contribution Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer (2022) Müller SK, Haderlein M, Lettmaier S, Agaimy A, Haller F, Hecht M, Fietkau R, et al. Journal article, Review article Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer (2022) Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, et al. Journal article Low-Dose Radiotherapy Leads to a Systemic Anti-Inflammatory Shift in the Pre-Clinical K/BxN Serum Transfer Model and Reduces Osteoarthritic Pain in Patients (2022) Weissmann T, Rückert M, Zhou J, Seeling M, Lettmaier S, Donaubauer AJ, Nimmerjahn F, et al. Journal article